DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR TROSPIUM CHLORIDE
Clinical Trials for Trospium Chloride
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT00465959 | Study of Trospium Chloride Inhalation Powder (TrIP) in Patients With Chronic Obstructive Pulmonary Disease | Completed | Alkermes, Inc. | Phase 1/Phase 2 | To assess the effect of a single dose of TrIP on pulmonary function in patients with COPD |
NCT00465959 | Study of Trospium Chloride Inhalation Powder (TrIP) in Patients With Chronic Obstructive Pulmonary Disease | Completed | Endo Pharmaceuticals | Phase 1/Phase 2 | To assess the effect of a single dose of TrIP on pulmonary function in patients with COPD |
NCT00800462 | Comparative Study of the Efficacy and Safety of Muscarinic M3 Receptors Antagonists in the Treatment of Neurogenic Detrusor Overactivity | Completed | Ontario Neurotrauma Foundation | Phase 4 | This is a phase IV, double-blind, multicenter, randomized trial evaluating the efficacy and safety of two M3 receptors antagonists (Trospium Chloride and Darifenacin Hydrobromide) with one standard drug (Oxybutynin Chloride) for treatment of overactive bladder in individuals with spinal cord injury. |
Trial ID | Title | Status | Sponsor | Phase | Summary |
Clinical Trial Conditions for Trospium Chloride
Condition Name
Condition MeSH
Clinical Trial Locations for Trospium Chloride
Trials by Country
Clinical Trial Progress for Trospium Chloride
Clinical Trial Phase
Clinical Trial Status
Clinical Trial Sponsors for Trospium Chloride
Sponsor Name